Atlas Trials

PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting

Clinical trial NCT03204279 · COMPLETED

Trial details

NCT number
NCT03204279
Sponsor
Helsinn Healthcare SA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-induced Nausea and Vomiting (CINV)
Start date
2017-08-31
Primary completion
2019-09-30
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.